Your browser doesn't support javascript.
loading
Characterization of the Active Components of the Multimerized sTNFRIIAdiponectin Fusion Protein Showing Both TNFα-Antagonizing and Glucose Uptake-Promoting Activities.
Wang, Yao; Lian, Hui; Wang, Xitong; Zheng, Tianyu; Yu, Xiaoxiao; Chen, Ruzhang; Huang, Zhiyong; Lv, Yinxiang; Zhao, Ai; Gao, Jimin.
Afiliação
  • Wang Y; Zhejiang Provincial Key Laboratory of Technology & Application of Model Organisms, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
  • Lian H; Zhejiang Provincial Key Laboratory of Technology & Application of Model Organisms, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
  • Wang X; Zhejiang Provincial Key Laboratory of Technology & Application of Model Organisms, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
  • Zheng T; Zhejiang Provincial Key Laboratory of Technology & Application of Model Organisms, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
  • Yu X; Zhejiang Provincial Key Laboratory of Technology & Application of Model Organisms, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
  • Chen R; Zhejiang Provincial Key Laboratory of Technology & Application of Model Organisms, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
  • Huang Z; Department of Thoracic Surgery Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Lv Y; Zhejiang Provincial Key Laboratory of Technology & Application of Model Organisms, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
  • Zhao A; Department of Hematology Shunde Hospital, Southern Medical University, Foshan, China; 4Zhejiang Qixin Biotech, Wenzhou, China.
  • Gao J; Zhejiang Provincial Key Laboratory of Technology & Application of Model Organisms, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
Endocr Metab Immune Disord Drug Targets ; 20(7): 1081-1089, 2020.
Article em En | MEDLINE | ID: mdl-31965947
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Fator de Necrose Tumoral alfa / Receptores Tipo II do Fator de Necrose Tumoral / Adiponectina / Glucose Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Endocr Metab Immune Disord Drug Targets Assunto da revista: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Fator de Necrose Tumoral alfa / Receptores Tipo II do Fator de Necrose Tumoral / Adiponectina / Glucose Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Endocr Metab Immune Disord Drug Targets Assunto da revista: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China